What Do We Know about Antiretroviral Treatment of HIV in Women?
- 1 February 2012
- journal article
- review article
- Published by SAGE Publications in Antiviral Therapy
- Vol. 18 (2_suppl) , 27-34
Abstract
As the number of women living with HIV continues to increase, the lack of sex-specific data on responses to antiretroviral therapy (ART) becomes increasingly problematic. Establishing the specific needs of women has been hampered by a strong male bias of study populations in clinical trials resulting in a lack of female-specific data for ART. The limited data currently available make it difficult to draw conclusions about the pharmacokinetic profile and clinical efficacy of ART in women. Data relating to the safety and tolerability profiles of ART in women are more plentiful, with indications that women may experience adverse event profiles distinct from those experienced by men. This, in turn, may be a factor in the generally higher rates of discontinuation of ART observed in women. Psychological and social aspects of HIV infection are particularly pertinent for women and girls, presenting potential barriers to diagnosis, access and adherence to therapy. Understanding these factors, in conjunction with an increase in clinical trial and real-world data specific to women with HIV is required to provide clearer guidance on optimum ART options for women.Keywords
This publication has 43 references indexed in Scilit:
- Abacavir/Lamivudine Versus Tenofovir DF/Emtricitabine as Part of Combination Regimens for Initial Treatment of HIV: Final ResultsThe Journal of Infectious Diseases, 2011
- Outcomes in the First Year after Initiation of First-Line Haart among Heterosexual Men and Women in the Uk Chic StudyAntiviral Therapy, 2011
- Comparative gender analysis of the efficacy and safety of atazanavir/ritonavir and lopinavir/ritonavir at 96 weeks in the CASTLE studyJournal of Antimicrobial Chemotherapy, 2010
- Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphomaAIDS, 2010
- Gender Differences in Discontinuation of Antiretroviral Treatment RegimensJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Women and HIV infection: The makings of a midlife crisisMaturitas, 2009
- Treatment Responses in Antiretroviral Treatment–Naive Premenopausal and Postmenopausal HIV‐1–Infected Women: An Analysis from AIDS Clinical Trials Group StudiesClinical Infectious Diseases, 2009
- Continuous antiretroviral therapy decreases bone mineral densityAIDS, 2009
- A comparison of the steady‐state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancyBritish Journal of Clinical Pharmacology, 2006
- Interpatient variability in the pharmacokinetics of the HIV non‐nucleoside reverse transcriptase inhibitor efavirenz: the effect of gender, race, and CYP2B6 polymorphismBritish Journal of Clinical Pharmacology, 2005